# Lipocine Inc.: Form 8-K, filed Oct 10, 2024

- Company: [Lipocine Inc.](/companies/lpcn.md) (CIK 1535955)
- Form: 8-K
- Filed: 2024-10-10
- Accepted by EDGAR: Oct 10, 2024, 06:04 ET
- Period: 2024-10-10
- Accession: 0001493152-24-040651
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1535955/000149315224040651/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1535955/000149315224040651/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1535955/000149315224040651/form8-k.htm

Filed Oct 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-040651. Last ingested by Listed: Nov 5, 2026, 12:44 ET. No prices; not investment advice.